Non-immunogenic, low-toxicity and effective glioma targeting MTI-31 liposomes
Xiaoyi Wang(Shanghai Medical College of Fudan University), Weiyue Lu(University of Shanghai for Science and Technology), Huitong Ruan(Shanghai Jiao Tong University), Kuan Jiang(Sun Yat-sen University), Ker Yu(Fudan University), Danni Ran(State Key Laboratory of Medical Neurobiology), Diane J. Burgess(University of Connecticut), Changyou Zhan(Shanghai Medical College of Fudan University), Huan Wang(Henan Agricultural University), Yanyu Zhang(Fudan University), Ruifeng Wang(Shenyang Pharmaceutical University), Nana Meng(Jiangsu University), Songli Wang(Amgen (United States)), Linwei Lu(Fudan University)
Cited by 49
Related Papers
DNA-based therapeutics and DNA delivery systems: A comprehensive review
|The AAPS Journal|2005|624
mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer.
|Endocrine Related Cancer|2001|418
Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect
|Journal of Controlled Release|2010|365
Biomimetic natural biomaterials for tissue engineering and regenerative medicine: new biosynthesis methods, recent advances, and emerging applications
|Military Medical Research|2023|333
Cancer Diagnosis: From Tumor to Liquid Biopsy and Beyond
|Lab on a Chip|2018|265